Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Orasure Tech Inc (OSUR)

Orasure Tech Inc (OSUR)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 741,044
  • Shares Outstanding, K 71,946
  • Annual Sales, $ 154,610 K
  • Annual Income, $ 16,660 K
  • 60-Month Beta -0.16
  • Price/Sales 4.50
  • Price/Cash Flow N/A
  • Price/Book 1.93
Trade OSUR with:

Options Overview

Details
  • Implied Volatility 98.90%
  • Historical Volatility 59.16%
  • IV Percentile 44%
  • IV Rank 30.57%
  • IV High 180.28% on 03/17/20
  • IV Low 63.07% on 11/25/20
  • Put/Call Vol Ratio 0.24
  • Today's Volume 304
  • Volume Avg (30-Day) 824
  • Put/Call OI Ratio 0.66
  • Today's Open Interest 13,949
  • Open Int (30-Day) 9,255

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/21
See More
  • Average Estimate 0.03
  • Number of Estimates 3
  • High Estimate 0.05
  • Low Estimate 0.01
  • Prior Year -0.10
  • Growth Rate Est. (year over year) +130.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
9.53 unch
on 03/08/21
14.75 -35.38%
on 02/10/21
-4.78 (-33.40%)
since 02/08/21
3-Month
9.53 unch
on 03/08/21
15.94 -40.21%
on 02/01/21
-3.97 (-29.41%)
since 12/08/20
52-Week
5.23 +82.22%
on 03/13/20
19.75 -51.75%
on 08/05/20
+3.61 (+60.98%)
since 03/06/20

Most Recent Stories

More News
OraSure Technologies (OSUR) Q4 Earnings Miss Estimates

OraSure (OSUR) delivered earnings and revenue surprises of -57.14% and 7.35%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

OSUR : 9.53 (-7.48%)
OraSure Technologies, Inc. Announces 2020 Full-Year and Fourth Quarter Financial Results and Provides COVID-19 Update

Full-Year 2020 Net Revenues of $172 Million Increased 11% Year-Over-Year, Driven by $50 Million in Sales of Oral Fluid Collection Devices for COVID-19 Molecular Testing

OSUR : 9.53 (-7.48%)
OraSure Technologies, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / March 1, 2021 / OraSure Technologies, Inc. (NASDAQ:OSUR) will be discussing their earnings results in their 2020 Fourth Quarter Earnings call to be held on March 1, 2021 at...

OSUR : 9.53 (-7.48%)
OraSure Technologies to Present at the Raymond James 42nd Annual Institutional Investors Conference

OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point of care diagnostic tests and specimen collection devices, and microbiome laboratory and analytical services, today announced that Dr. Stephen...

OSUR : 9.53 (-7.48%)
OraSure Technologies (OSUR) Reports Next Week: Wall Street Expects Earnings Growth

OraSure (OSUR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

OSUR : 9.53 (-7.48%)
2020 Fourth Quarter Earnings Conference Call Monday, March 1, 2021, 5:00 p.m. ET

OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering 2020 fourth quarter financial results and certain business developments for 5:00 pm ET (2:00 pm PT)...

OSUR : 9.53 (-7.48%)
OraSure Technologies (OSUR) to Report Q4 Results: Wall Street Expects Earnings Growth

OraSure (OSUR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

OSUR : 9.53 (-7.48%)
OraSure Subsidiary DNA Genotek's OMNIgene(R)-- ORAL Included in EUA Granted to Ambry Genetics for Use in COVID-19 RT-PCR Saliva Test

OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services, today announced its OMNIgene(R)--...

OSUR : 9.53 (-7.48%)
ResMed (RMD) Q2 Earnings Surpass Estimates, Margins Rise

ResMed (RMD) reported second-quarter fiscal 2021 revenues of $800 million, up 9% from a year ago.

RMD : 179.46 (-3.02%)
VIVO : 22.13 (+1.00%)
OSUR : 9.53 (-7.48%)
SURF : 7.36 (-1.87%)
Smith+Nephew's (SNN) PICO sNPWT Study Outcome Encouraging

Smith+Nephew's (SNN) PICO Single Use Negative Pressure Wound Therapy System (sNPWT) considerably reduces surgical site infections complications and provides better patient outcome.

SNN : 37.94 (-1.53%)
VIVO : 22.13 (+1.00%)
OSUR : 9.53 (-7.48%)
MYO : 10.62 (-5.93%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

OraSure Technologies, Inc. develops, manufactures and markets oral fluid specimen collection devices using proprietary oral fluid technologies, diagnostic products including immunoassays and other in vitro diagnostic tests, and other medical devices. These products are sold in the United States as well...

See More

Key Turning Points

3rd Resistance Point 10.83
2nd Resistance Point 10.57
1st Resistance Point 10.05
Last Price 9.53
1st Support Level 9.27
2nd Support Level 9.01
3rd Support Level 8.49

See More

52-Week High 19.75
Fibonacci 61.8% 14.20
Fibonacci 50% 12.49
Fibonacci 38.2% 10.78
Last Price 9.53
52-Week Low 5.23

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar